Nalaganje...
Efficacy of JAK inhibitors in Ulcerative Colitis
Janus kinase [JAK] inhibitors are a completely novel therapy for the treatment of patients with immune-mediated inflammatory disorders. The oral formulation of tofacitinib has recently been approved for the treatment of moderate-to-severe ulcerative colitis. In the placebo-controlled OCTAVE programm...
Shranjeno v:
| izdano v: | J Crohns Colitis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395310/ https://ncbi.nlm.nih.gov/pubmed/31879750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjz202 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|